Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 177

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 177
---
 his or her terms of employment, in each case with
a term of more than three years requires the abovementioned approval every three years, however, transactions not involving the receipt
of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable
under the circumstances. In addition, transactions with a controlling shareholder or a controlling shareholder’s relative who serves
as an officer in a company, directly or indirectly (including through a corporation under his control), involving the receipt of services
by a company or their compensation can have a term of five years from the company’s initial public offering under certain circumstances.

Arrangements regarding the
compensation, indemnification or insurance of a controlling shareholder in his or her capacity as an office holder require the approval
of the compensation committee, board of directors and shareholders by a Special Majority and the terms thereof may not be inconsistent
with the company’s stated compensation policy.

Pursuant to regulations promulgated
under the Companies Law, certain transactions and arrangements with a controlling shareholder or his or her relative, or with directors
or office holders, which would otherwise require approval of a company’s shareholders, may be exempt from shareholder approval under
certain conditions.

The Companies Law requires
that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling
shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question.
Failure to so indicate will result in the invalidation of that shareholder’s vote. However, according to the Companies Law Regulations
(exemptions for companies whose securities are listed for trading on a stock exchange outside of Israel) 5760-2000 that apply to the Company,
by signing and submitting a proxy card, a shareholder declares and approves that he has no personal interest in the approval of any of
the items on a general meeting agenda that requires such declaration under the Companies Law, with the exception of a personal interest
that the shareholder positively informed the company about.

Disclosure of Compensation of Executive Officers

For so long as we qualify
as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies, including the requirement
applicable to emerging growth companies to disclose the compensation of our chief executive officer and other two most highly compensated
executive officers on an individual, rather than an aggregate, basis. Nevertheless, regulations promulgated under the Companies Law